MLICM
CNDT icon

Metropolitan Life Insurance Company (MetLife)’s Conduent CNDT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CNDT Stock Details CNDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,035
Closed -$23.8K – 461
2024
Q1 		$23.8K Sell
7,035
-71
-1% -$246 ﹤0.01% 1775
2023
Q4 		$25.9K Sell
7,106
-2,051
-22% -$6.49K ﹤0.01% 1800
2023
Q3 		$31.9K Hold
9,157
– – ﹤0.01% 1648
2023
Q2 		$31.1K Hold
9,157
– – ﹤0.01% 1700
2023
Q1 		$31.4K Sell
9,157
-1,105
-11% -$4.54K ﹤0.01% 1650
2022
Q4 		$41.6K Hold
10,262
– – ﹤0.01% 1583
2022
Q3 		$34.3K Buy
10,262
+2,166
+27% +$9.04K ﹤0.01% 1716
2022
Q2 		$35K Sell
8,096
-2,506
-24% -$12.6K ﹤0.01% 1721
2022
Q1 		$54.7K Sell
10,602
-32,638
-75% -$161K ﹤0.01% 1545
2021
Q4 		$231K Buy
43,240
+5,610
+15% +$33.5K ﹤0.01% 1926
2021
Q3 		$248K Sell
37,630
-6,502
-15% -$44.7K ﹤0.01% 1916
2021
Q2 		$331K Buy
44,132
+8,398
+24% +$61.3K ﹤0.01% 1782
2021
Q1 		$238K Sell
35,734
-9,565
-21% -$54.5K ﹤0.01% 1896
2020
Q4 		$217K Sell
45,299
-1,341
-3% -$5.6K ﹤0.01% 1887
2020
Q3 		$148K Sell
46,640
-8,205
-15% -$24.3K ﹤0.01% 1967
2020
Q2 		$131K Buy
54,845
+254
+0.5% +$591 ﹤0.01% 2093
2020
Q1 		$134K Buy
54,591
+855
+2% +$3.39K ﹤0.01% 1846
2019
Q4 		$333K Buy
53,736
+5,134
+11% +$32.1K 0.01% 1576
2019
Q3 		$302K Buy
48,602
+31,754
+188% +$245K 0.01% 1606
2019
Q2 		$162K Buy
16,848
+12,234
+265% +$132K ﹤0.01% 2032
2019
Q1 		$63.8K Sell
4,614
-71
-2% -$945 ﹤0.01% 2493
2018
Q4 		$49.8K Buy
4,685
+36
+0.8% +$561 ﹤0.01% 2507
2018
Q3 		$105K Sell
4,649
-474
-9% -$9.73K ﹤0.01% 2425
2018
Q2 		$93.1K Sell
5,123
-365
-7% -$7.05K ﹤0.01% 2361
2018
Q1 		$102K Buy
5,488
+9
+0.2% +$158 ﹤0.01% 2284
2017
Q4 		$89K Sell
5,479
-206
-4% -$3.22K ﹤0.01% 2370
2017
Q3 		$89K Buy
5,685
+520
+10% +$8.49K ﹤0.01% 2418
2017
Q2 		$82K Sell
5,165
-604
-10% -$9.89K ﹤0.01% 2523
2017
Q1 		$97K Buy
+5,769
New +$87.8K ﹤0.01% 2445

Other funds holding CNDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CNDT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Conduent (CNDT) in Q2 2024, closing a stake of 7,035 shares — an estimated $23.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CNDT in Q1 2017 and held it in 29 quarters. The position peaked at $333K in Q4 2019. 202 funds tracked by Wall St. Rank hold CNDT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Conduent position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 7,035 Conduent shares in Q2 2024, an estimated $23.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Conduent in Q1 2017 and held it in 29 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Conduent position peaked at $333K in Q4 2019.
  • 202 funds tracked by Wall St. Rank held Conduent as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.